why choose us

First received: September 19, 2024

Clinical Trial: Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Parkinson Disease
Multiple System Atrophy

Study Type: INTERVENTIONAL


Official Title: A Phase 2a, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Dosing of Exidavnemab in Patients With Mild to Moderate

Brief Summary: The primary objective of this study is to assess the safety and tolerability of exidavnemab after multiple dosing versus placebo.

Read more